Tern Therapeutics
PrivateLast Round
Series A
Aug 27, 2024
Total Funding Raised
$15M
Company Overview
Tern Therapeutics is a biotechnology company that develops transformative, one-time gene therapy medicines for rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tern Therapeutics Comparables
Compare Tern Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neela Therapeutics | 84% | |
| LEXEO Therapeutics | 80% | |
| Abeona Therapeutics Inc. | 78% |
Tern Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 27, 2024 |
Key People
Founding team and executive leadership
Tern Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ATW Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors grew 111% MoM.
- Aug 27, 2024
$15M round led by ATW Partners.
Tern Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tern Therapeutics's valuation, stock price, and market status.
Is Tern Therapeutics a public or private company?
Tern Therapeutics is a private company.
What is the current stock price of Tern Therapeutics?
Tern Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Tern Therapeutics worth (valuation)?
Valuation information for Tern Therapeutics is not publicly available.
Can I buy Tern Therapeutics stock?
Tern Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tern Therapeutics's last funding round?
Tern Therapeutics's most recent funding round was Series A on August 27, 2024.
Who are the main investors in Tern Therapeutics?
Key investors in Tern Therapeutics include ATW Partners.
Will Tern Therapeutics IPO soon?
No public IPO plans have been announced for Tern Therapeutics.
How can I track Tern Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tern Therapeutics's secondary market activity and sign up for updates.